Diuretic medicine sales in Spain experienced several fluctuations from 2013 to 2023. Starting at 2.9 USD per capita in 2013, the value dropped significantly to 2.2 USD by 2015, then gradually increased and peaked at 3.2 USD in 2021. However, by 2023, it stabilized at 2.7 USD per capita. The 2023 figures represent a 0% change year-on-year from 2022.
Year-on-year variation analysis reveals a significant drop of 15.62% in 2022, followed by stabilization in 2023. The Compound Annual Growth Rate (CAGR) for the previous five years (ending 2023) indicates a slight decline of -0.72% per year.
Looking forward, forecasted data from 2024 to 2028 show a gradual decline, with values decreasing to 2.5 USD per capita by 2028. The forecasted average annual decrease (CAGR) for the next five years is about -1.53%, amounting to an overall contraction of 7.41% by 2028.
Future Trends to Watch for:
Potential influences on future diuretic sales include changes in healthcare policies, advancements in medical treatments, demographic shifts, and lifestyle-related health issues. Monitoring these factors will be crucial in understanding and predicting upcoming market trends.
